Release Date: 31/01/12 10:51 Summary: Dec 2011 Quarterly Activities_Cashflow Report 31-01-12 Price Sensitive: Yes Download Document 209.52KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%